Europe's pharma industry braces for tariffs as carve-out hopes fade

For now, pharmaceuticals will be safe from the radical tariffs applied by America’s major trading partners, a small victory for pharmaceutical companies that have been pushing for a tax exemption. President Donald Trump announced on Wednesday, April 2, the imposition of reciprocal tariffs on more than 60 countries, including members of the European Union and Switzerland. Trump has previously said that tariffs specifically targeted at the pharmac…

Austria's economy expects up to two billion euros to be damaged by the new US tariffs, as a first analysis shows. However, exceptions remain for a large part of imports into the US, including pharmaceutical products such as weight loss medicines.

German chemicals industry calls on EU to avoid 'escalation' as the world reacts to Trump's tariffs

The United States is the most important export market for German chemical products outside the EU and absorbs almost a quarter of the country's pharmaceutical exports.

After saying overseas drugmakers would have a “big tax to pay,” Trump spares pharmaceuticals from reciprocal tariffs

Despite plenty of presidential tough talk, European drugmakers appear to have been spared from the tariff buzzsaw — at least for now....

Europe braces for Trump’s tariffs: What could the economic damage be?

Trump’s tariffs on EU goods could slash exports by at least €85 billion, hitting autos and pharmaceuticals hardest. Germany, Denmark and Central Europe face sharp fallout, raising recession risks and forcing the ECB to consider rate cuts.

Europe's pharma industry braces for tariffs as carve-out hopes fade

Europe's pharmaceutical sector is bracing for the potential impact of U.S. tariffs as hopes of an industry-wide exemption by President Donald Trump fade.